1
|
Evin M, Koumeir C, Bongrand A, Delpon G, Haddad F, Mouchard Q, Potiron V, Saade G, Servagent N, Villoing D, Métivier V, Chiavassa S. Methodology for small animals targeted irradiations at conventional and ultra-high dose rates 65 MeV proton beam. Phys Med 2024; 120:103332. [PMID: 38518627 DOI: 10.1016/j.ejmp.2024.103332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/26/2023] [Revised: 02/20/2024] [Accepted: 03/11/2024] [Indexed: 03/24/2024] Open
Abstract
As part of translational research projects, mice may be irradiated on radiobiology platforms such as the one at the ARRONAX cyclotron. Generally, these platforms do not feature an integrated imaging system. Moreover, in the context of ultra-high dose-rate radiotherapy (FLASH-RT), treatment planning should consider potential changes in the beam characteristics and internal movements in the animal. A patient-like set-up and methodology has been implemented to ensure target coverage during conformal irradiations of the brain, lungs and intestines. In addition, respiratory cycle amplitudes were quantified by fluoroscopic acquisitions on a mouse, to ensure organ coverage and to assess the impact of respiration during FLASH-RT using the 4D digital phantom MOBY. Furthermore, beam incidence direction was studied from mice µCBCT and Monte Carlo simulations. Finally,in vivodosimetry with dose-rate independent radiochromic films (OC-1) and their LET dependency were investigated. The immobilization system ensures that the animal is held in a safe and suitable position. The geometrical evaluation of organ coverage, after the addition of the margins around the organs, was satisfactory. Moreover, no measured differences were found between CONV and FLASH beams enabling a single model of the beamline for all planning studies. Finally, the LET-dependency of the OC-1 film was determined and experimentally verified with phantoms, as well as the feasibility of using these filmsin vivoto validate the targeting. The methodology developed ensures accurate and reproducible preclinical irradiations in CONV and FLASH-RT without in-room image guidance in terms of positioning, dose calculation andin vivodosimetry.
Collapse
Affiliation(s)
- Manon Evin
- Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France.
| | - Charbel Koumeir
- Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France; GIP ARRONAX, Saint-Herblain, France
| | - Arthur Bongrand
- GIP ARRONAX, Saint-Herblain, France; Institut de Cancérologie de l'Ouest, site de Saint-Herblain, France
| | - Gregory Delpon
- Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France; Institut de Cancérologie de l'Ouest, site de Saint-Herblain, France
| | - Ferid Haddad
- Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France; GIP ARRONAX, Saint-Herblain, France
| | - Quentin Mouchard
- Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France
| | - Vincent Potiron
- Institut de Cancérologie de l'Ouest, site de Saint-Herblain, France; Nantes Université, CNRS, US2B, UMR 6286, F-44000 Nantes, France
| | - Gaëlle Saade
- Nantes Université, CNRS, US2B, UMR 6286, F-44000 Nantes, France
| | - Noël Servagent
- Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France
| | - Daphnée Villoing
- Institut de Cancérologie de l'Ouest, site de Saint-Herblain, France
| | - Vincent Métivier
- Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France
| | - Sophie Chiavassa
- Nantes Université, IMT Atlantique, CNRS/IN2P3, SUBATECH, F-44000 Nantes, France; Institut de Cancérologie de l'Ouest, site de Saint-Herblain, France
| |
Collapse
|
2
|
Daher A, Payne S. The conducted vascular response as a mediator of hypercapnic cerebrovascular reactivity: A modelling study. Comput Biol Med 2024; 170:107985. [PMID: 38245966 DOI: 10.1016/j.compbiomed.2024.107985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2023] [Revised: 12/29/2023] [Accepted: 01/13/2024] [Indexed: 01/23/2024]
Abstract
It is well established that the cerebral blood flow (CBF) shows exquisite sensitivity to changes in the arterial blood partial pressure of CO2 ( [Formula: see text] ), which is reflected by an index termed cerebrovascular reactivity. In response to elevations in [Formula: see text] (hypercapnia), the vessels of the cerebral microvasculature dilate, thereby decreasing the vascular resistance and increasing CBF. Due to the challenges of access, scale and complexity encountered when studying the microvasculature, however, the mechanisms behind cerebrovascular reactivity are not fully understood. Experiments have previously established that the cholinergic release of the Acetylcholine (ACh) neurotransmitter in the cortex is a prerequisite for the hypercapnic response. It is also known that ACh functions as an endothelial-dependent agonist, in which the local administration of ACh elicits local hyperpolarization in the vascular wall; this hyperpolarization signal is then propagated upstream the vascular network through the endothelial layer and is coupled to a vasodilatory response in the vascular smooth muscle (VSM) layer in what is known as the conducted vascular response (CVR). Finally, experimental data indicate that the hypercapnic response is more strongly correlated with the CO2 levels in the tissue than in the arterioles. Accordingly, we hypothesize that the CVR, evoked by increases in local tissue CO2 levels and a subsequent local release of ACh, is responsible for the CBF increase observed in response to elevations in [Formula: see text] . By constructing physiologically grounded dynamic models of CBF and control in the cerebral vasculature, ones that integrate the available knowledge and experimental data, we build a new model of the series of signalling events and pathways underpinning the hypercapnic response, and use the model to provide compelling evidence that corroborates the aforementioned hypothesis. If the CVR indeed acts as a mediator of the hypercapnic response, the proposed mechanism would provide an important addition to our understanding of the repertoire of metabolic feedback mechanisms possessed by the brain and would motivate further in-vivo investigation. We also model the interaction of the hypercapnic response with dynamic cerebral autoregulation (dCA), the collection of mechanisms that the brain possesses to maintain near constant CBF despite perturbations in pressure, and show how the dCA mechanisms, which otherwise tend to be overlooked when analysing experimental results of cerebrovascular reactivity, could play a significant role in shaping the CBF response to elevations in [Formula: see text] . Such in-silico models can be used in tandem with in-vivo experiments to expand our understanding of cerebrovascular diseases, which continue to be among the leading causes of morbidity and mortality in humans.
Collapse
Affiliation(s)
- Ali Daher
- Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, United Kingdom.
| | - Stephen Payne
- Institute of Applied Mechanics, National Taiwan University, Taiwan
| |
Collapse
|
3
|
Potiron V, Delpon G, Ollivier L, Vaugier L, Doré M, Guimas V, Rio E, Thillays F, Llagostera C, Moignier A, Josset S, Chiavassa S, Perennec T, Supiot S. [Clinical research in radiation oncology: how to move from the laboratory to the patient?]. Cancer Radiother 2022; 26:808-813. [PMID: 35999162 DOI: 10.1016/j.canrad.2022.07.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Revised: 07/05/2022] [Accepted: 07/06/2022] [Indexed: 11/19/2022]
Abstract
Translational research in radiation oncology is undergoing intense development. An increasingly rapid transfer is taking place from the laboratory to the patients, both in the selection of patients who can benefit from radiotherapy and in the development of innovative irradiation strategies or the development of combinations with drugs. Accelerating the passage of discoveries from the laboratory to the clinic represents the ideal of any translational research program but requires taking into account the multiple obstacles that can slow this progress. The ambition of the RadioTransNet network, a project to structure preclinical research in radiation oncology in France, is precisely to promote scientific and clinical interactions at the interface of radiotherapy and radiobiology, in its preclinical positioning, in order to identify priorities for strategic research dedicated to innovation in radiotherapy. The multidisciplinary radiotherapy teams with experts in biology, medicine, medical physics, mathematics and engineering sciences are able to meet these new challenges which will allow these advances to be made available to patients as quickly as possible.
Collapse
Affiliation(s)
- V Potiron
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France; Unité en sciences biologiques et biotechnologies, UMR CNRS 6286, 2, rue de la Houssinière, 44322 Nantes, France
| | - G Delpon
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France; IMT Atlantique, UMR CNRS 6457/IN2P3, Subatech, laboratoire de physique subatomique et des technologies associées, Nantes, France
| | - L Ollivier
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France
| | - L Vaugier
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France
| | - M Doré
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France
| | - V Guimas
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France
| | - E Rio
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France
| | - F Thillays
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France
| | - C Llagostera
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France
| | - A Moignier
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France
| | - S Josset
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France
| | - S Chiavassa
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France; IMT Atlantique, UMR CNRS 6457/IN2P3, Subatech, laboratoire de physique subatomique et des technologies associées, Nantes, France
| | - T Perennec
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France
| | - S Supiot
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44800 Saint-Herblain, France; Unité en sciences biologiques et biotechnologies, UMR CNRS 6286, 2, rue de la Houssinière, 44322 Nantes, France.
| |
Collapse
|
4
|
Ma D, Gao R, Li M, Qiu J. Mechanical and medical imaging properties of 3D-printed materials as tissue equivalent materials. J Appl Clin Med Phys 2022; 23:e13495. [PMID: 34878729 PMCID: PMC8833282 DOI: 10.1002/acm2.13495] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2021] [Revised: 07/12/2021] [Accepted: 11/18/2021] [Indexed: 12/21/2022] Open
Abstract
Three materials of polylactic acid (PLA), polyamide 12 (PA12), and light curing resin (LCR) were used to construct phantom using 3D printing technology. The mechanical and medical imaging properties of the three materials, such as elastic modulus, density, effective atomic number, X-ray attenuation coefficient, computed tomography (CT) number, and acoustic properties, were investigated. The results showed that the elastic modulus for PLA was 1.98 × 103 MPa, for PA12 was 848 MPa, for LCR was 1.18×103 MPa, and that of three materials was close to some bones. In the range of 40∼120 kV, the X-ray attenuation coefficient of three materials decreased with increasing tube voltage. The CT number for PLA, PA12, and LCR was 144, -88, and 312 Hounsfield units at 120 kV tube voltage, respectively. The density and the effective atomic number product (ρ*Zeff ) were computed from three materials and decreased in the order of LCR, PLA, and PA12. The acoustic properties of materials were also studied. The speeds of sound of three materials were similar with those of some soft tissues.
Collapse
Affiliation(s)
- Depeng Ma
- Medical Engineering and Technology CenterShandong First Medical University and Shandong Academy of Medical SciencesTaianP. R. China
- Qingdao 3E3D Tech. Co. Ltd.QingdaoP. R. China
| | - Ronghui Gao
- Health Care DepartmentTaishan Sanatorium of ShandongProvinceTaianP. R. China
| | - Minghui Li
- Medical Engineering and Technology CenterShandong First Medical University and Shandong Academy of Medical SciencesTaianP. R. China
| | - Jianfeng Qiu
- Medical Engineering and Technology CenterShandong First Medical University and Shandong Academy of Medical SciencesTaianP. R. China
- Medical Science and Technology Innovation CenterShandong First Medical University and Shandong Academy of Medical SciencesJi'nanP. R. China
- Qingdao 3E3D Tech. Co. Ltd.QingdaoP. R. China
| |
Collapse
|
5
|
Bongrand A, Koumeir C, Villoing D, Guertin A, Haddad F, Métivier V, Poirier F, Potiron V, Servagent N, Supiot S, Delpon G, Chiavassa S. A Monte Carlo Determination of Dose and Range Uncertainties for Preclinical Studies with a Proton Beam. Cancers (Basel) 2021; 13:1889. [PMID: 33920758 PMCID: PMC8071150 DOI: 10.3390/cancers13081889] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2021] [Revised: 04/09/2021] [Accepted: 04/12/2021] [Indexed: 11/17/2022] Open
Abstract
Proton therapy (PRT) is an irradiation technique that aims at limiting normal tissue damage while maintaining the tumor response. To study its specificities, the ARRONAX cyclotron is currently developing a preclinical structure compatible with biological experiments. A prerequisite is to identify and control uncertainties on the ARRONAX beamline, which can lead to significant biases in the observed biological results and dose-response relationships, as for any facility. This paper summarizes and quantifies the impact of uncertainty on proton range, absorbed dose, and dose homogeneity in a preclinical context of cell or small animal irradiation on the Bragg curve, using Monte Carlo simulations. All possible sources of uncertainty were investigated and discussed independently. Those with a significant impact were identified, and protocols were established to reduce their consequences. Overall, the uncertainties evaluated were similar to those from clinical practice and are considered compatible with the performance of radiobiological experiments, as well as the study of dose-response relationships on this proton beam. Another conclusion of this study is that Monte Carlo simulations can be used to help build preclinical lines in other setups.
Collapse
Affiliation(s)
- Arthur Bongrand
- Institut de Cancérologie de l’Ouest, 44800 Saint-Herblain, France; (A.B.); (D.V.); (V.P.); (S.S.); (G.D.)
| | - Charbel Koumeir
- GIP ARRONAX, 44800 Saint-Herblain, France; (C.K.); (F.H.); (F.P.)
| | - Daphnée Villoing
- Institut de Cancérologie de l’Ouest, 44800 Saint-Herblain, France; (A.B.); (D.V.); (V.P.); (S.S.); (G.D.)
| | - Arnaud Guertin
- Laboratoire SUBATECH, UMR 6457, CNRS IN2P3, IMT Atlantique, Université de Nantes, 44307 Nantes, France; (A.G.); (V.M.); (N.S.)
| | - Ferid Haddad
- GIP ARRONAX, 44800 Saint-Herblain, France; (C.K.); (F.H.); (F.P.)
- Laboratoire SUBATECH, UMR 6457, CNRS IN2P3, IMT Atlantique, Université de Nantes, 44307 Nantes, France; (A.G.); (V.M.); (N.S.)
| | - Vincent Métivier
- Laboratoire SUBATECH, UMR 6457, CNRS IN2P3, IMT Atlantique, Université de Nantes, 44307 Nantes, France; (A.G.); (V.M.); (N.S.)
| | - Freddy Poirier
- GIP ARRONAX, 44800 Saint-Herblain, France; (C.K.); (F.H.); (F.P.)
| | - Vincent Potiron
- Institut de Cancérologie de l’Ouest, 44800 Saint-Herblain, France; (A.B.); (D.V.); (V.P.); (S.S.); (G.D.)
| | - Noël Servagent
- Laboratoire SUBATECH, UMR 6457, CNRS IN2P3, IMT Atlantique, Université de Nantes, 44307 Nantes, France; (A.G.); (V.M.); (N.S.)
| | - Stéphane Supiot
- Institut de Cancérologie de l’Ouest, 44800 Saint-Herblain, France; (A.B.); (D.V.); (V.P.); (S.S.); (G.D.)
| | - Grégory Delpon
- Institut de Cancérologie de l’Ouest, 44800 Saint-Herblain, France; (A.B.); (D.V.); (V.P.); (S.S.); (G.D.)
| | - Sophie Chiavassa
- Institut de Cancérologie de l’Ouest, 44800 Saint-Herblain, France; (A.B.); (D.V.); (V.P.); (S.S.); (G.D.)
| |
Collapse
|
6
|
Chiavassa S, Nilsson R, Clément-Colmou K, Potiron V, Delpon G, Traneus E. Validation of the analytical irradiator model and Monte Carlo dose engine in the small animal irradiation treatment planning system µ-RayStation 8B. Phys Med Biol 2020; 65:035006. [PMID: 31829982 DOI: 10.1088/1361-6560/ab6155] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Dose calculation in preclinical context with a clinical level of accuracy is a challenge due to the small animal scale and the medium photon energy range. In this work, we evaluate the effectiveness and accuracy of an analytical irradiator model combined with Monte Carlo (MC) calculations in the irradiated volume to calculate the dose delivered by a modern small animal irradiator. A model of the XRAD225Cx was created in µ-RayStation 8B, a preclinical treatment planning system, allowing arc and static beams for seven cylindrical collimators. Calculations with the µ-RayStation MC dose engine were compared with EBT3 measurements in water for all static beams and with a validated GATE model in water, heterogeneous media and a mouse CT. The GATE model is a complete MC representation of the XRAD225Cx. In water, µ-RayStation calculations, compared to GATE calculations and EBT3 measurements, agreed within a maximal error of 3.2% (mean absolute error of 0.6% and 0.8% respectively) and maximal distance-to-agreement (DTA) was 0.2 mm at 50% of the central dose. For a 5 mm static beam in heterogeneous media, the maximal absolute error between µ-RayStation and GATE calculations was below 1.3% in each medium and DTA was 0.1 mm at interfaces. For calculations on a mouse CT, µ-RayStation and GATE calculations agreed well for both static and arc beams. The 2D local gamma passing rate was >98.9% for 1%/0.3 mm criteria and >92.9% for 1%/0.2 mm criteria. Moreover, µ-RayStation reduces calculation time significantly comparing with GATE (speed-up factor between 120 and 680). These findings show that the analytical irradiator model presented in this work combined with the µ-RayStation MC dose engine accurately computes dose for the XRAD225Cx irradiator. The improvements in calculation time and availability of functionality and tools for managing, planning and evaluating the irradiation makes this platform very useful for pre-clinical irradiation research.
Collapse
Affiliation(s)
- S Chiavassa
- Institut de Cancérologie de l'Ouest, Nantes, France. Author to whom any correspondence should be addressed
| | | | | | | | | | | |
Collapse
|
7
|
Woods K, Neph R, Nguyen D, Sheng K. A sparse orthogonal collimator for small animal intensity-modulated radiation therapy. Part II: hardware development and commissioning. Med Phys 2019; 46:5733-5747. [PMID: 31621091 DOI: 10.1002/mp.13870] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2019] [Revised: 10/07/2019] [Accepted: 10/09/2019] [Indexed: 12/18/2022] Open
Abstract
PURPOSE A dose-modulation device for small animal radiotherapy is required to use clinically analogous treatment techniques, which will likely increase the translatability of preclinical research results. Because the clinically used multileaf collimator (MLC) is impractical for miniaturization, we have developed a simpler, better-suited sparse orthogonal collimator (SOC) for delivering small animal intensity-modulated radiation therapy (IMRT) using a rectangular aperture optimization (RAO) treatment planning system. METHODS The SOC system was modeled in computer-aided design software and fabricated with machined tungsten leaves and three-dimensional (3D) printed leaf housing. A graphical user interface was developed for controlling and calibrating the SOC leaves, which are driven by Arduino-controlled stepper motors. A Winston-Lutz test was performed to assess mechanical alignment, and abutting field and grid dose patterns were created to analyze intra- and intercalibration leaf positioning error. Leaf transmission and penumbra were measured over the full range of gantry angles and leaf positions, respectively. Three SOC test plans were delivered, and film measurements were compared to the intended dose distributions. The differences in maximum, mean, and minimum, as well as pixelwise absolute dose differences, were compared for each structure, and a gamma analysis was performed for the target structures using criteria of 4% dose difference and 0.3 mm distance to agreement. RESULTS The Winston-Lutz test revealed maximum directional offsets between the SOC and primary collimator axes of 0.53 mm at 0° and 0.68 mm over the full 360°. Upper and lower abutting field patterns had maximum dose deviations of 18.8 ± 3.1% and 15.5 ± 2.9%, respectively, and grid patterns showed intra- and intercalibration repeatability of 93% and 91%, respectively. Extremely low midleaf (0.15 ± 0.05%) and interleaf (0.27 ± 0.22%) transmission was measured, with no significant rotational variation. The average penumbra was ~0.8 mm for all leaves at field center, with a range of 0.17 mm for all leaf positions. A highly concave test plan was delivered with a ~ 95% gamma analysis pass rate, and a realistic mouse phantom liver irradiation plan achieved a pass rate of ~98%. A highly complex dose distribution was also created with 551 SOC apertures averaging 2.4 mm in size. CONCLUSIONS A sparse orthogonal collimator was developed and commissioned, with promising preliminary dosimetry results. The SOC design, with its limited moving components and high dose-modulation resolution, is ideal for delivering high-quality small animal IMRT with our RAO-based treatment planning system.
Collapse
Affiliation(s)
- Kaley Woods
- Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA
| | - Ryan Neph
- Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA
| | - Dan Nguyen
- Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA
| | - Ke Sheng
- Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA
| |
Collapse
|
8
|
Biglin ER, Price GJ, Chadwick AL, Aitkenhead AH, Williams KJ, Kirkby KJ. Preclinical dosimetry: exploring the use of small animal phantoms. Radiat Oncol 2019; 14:134. [PMID: 31366364 PMCID: PMC6670203 DOI: 10.1186/s13014-019-1343-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2019] [Accepted: 07/22/2019] [Indexed: 11/16/2022] Open
Abstract
Preclinical radiotherapy studies using small animals are an indispensable step in the pathway from in vitro experiments to clinical implementation. As radiotherapy techniques advance in the clinic, it is important that preclinical models evolve to keep in line with these developments. The use of orthotopic tumour sites, the development of tissue-equivalent mice phantoms and the recent introduction of image-guided small animal radiation research platforms has enabled similar precision treatments to be delivered in the laboratory. These technological developments, however, are hindered by a lack of corresponding dosimetry standards and poor reporting of methodologies. Without robust and well documented preclinical radiotherapy quality assurance processes, it is not possible to ensure the accuracy and repeatability of dose measurements between laboratories. As a consequence current RT-based preclinical models are at risk of becoming irrelevant. In this review we explore current standardization initiatives, focusing in particular on recent developments in small animal irradiation equipment, 3D printing technology to create customisable tissue-equivalent dosimetry phantoms and combining these phantoms with commonly used detectors.
Collapse
Affiliation(s)
- Emma R Biglin
- Division of Cancer Sciences, University of Manchester, Manchester Cancer Research Centre, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK.
| | - Gareth J Price
- Division of Cancer Sciences, University of Manchester, Manchester Cancer Research Centre, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK.,The Christie NHS Foundation Trust, Manchester, UK
| | - Amy L Chadwick
- Division of Cancer Sciences, University of Manchester, Manchester Cancer Research Centre, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK.,The Christie NHS Foundation Trust, Manchester, UK
| | - Adam H Aitkenhead
- Division of Cancer Sciences, University of Manchester, Manchester Cancer Research Centre, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK.,The Christie NHS Foundation Trust, Manchester, UK
| | - Kaye J Williams
- Division of Pharmacy and Optometry, University of Manchester, Manchester, UK
| | - Karen J Kirkby
- Division of Cancer Sciences, University of Manchester, Manchester Cancer Research Centre, 3rd floor Proton Beam Therapy Centre, Oak Road, Manchester, M20 4BX, UK.,The Christie NHS Foundation Trust, Manchester, UK
| |
Collapse
|
9
|
Le Deroff C, Frelin AM, Ledoux X. Energy dependence of a scintillating fiber detector for preclinical dosimetry with an image guided micro-irradiator. Phys Med Biol 2019; 64:115015. [PMID: 30974415 DOI: 10.1088/1361-6560/ab1854] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
The dosimetry of preclinical micro-irradiators is challenging due to their millimetric beams and medium x-ray energy range. Plastic scintillator dosimeters (PSD) are good candidates for such a purpose as they provide a high spatial resolution although they show an energy dependence below 100 keV. The purpose of this study was to assess the energy dependence of a dedicated PSD (called DosiRat) for micro-irradiators dosimetry. The response of the PSD relative to air kerma was measured for different beam qualities (40-225 kV) with the X-RAD 225Cx irradiator. The corresponding energy spectra, determined by Monte Carlo simulations, allowed for correcting the differences in absorbed dose between the DosiRat material (polystyrene) and the air and therefore allowed to compare DosiRat intrinsic energy response to the Birks scintillation quenching model. The energy response of DosiRat was then assessed under preclinical conditions through percentage depth dose curves (PDD) and relative output factor (ROF) measurements in water for beam diameters ranging from 1 to 25 mm. DosiRat energy response showed a coefficient of variation of 23% from 40 to 225 kV, mainly explained by the mass energy-absorption coefficient variation between polystyrene and air. A remaining variation was shown to be caused by the quenching of the scintillation and was correctly reproduced by the Birks model (with kB = 10.27 mg MeV-1 cm-2). PDD and ROF measurements highlighted an energy response variation with depth and collimation up to 10%. A dose accuracy better than 1% was finally achieved with appropriate calibration and correction factors (CF), for beam collimations larger than the detector ([Formula: see text]2 mm diameter). DosiRat energy dependence was fully characterized in preclinical energy range and shown to be negligible with convenient calibration and corrections factors. It provided accurate dosimetry for medium energy (225 kV) and millimetric beams (down to 2.5 mm).
Collapse
Affiliation(s)
- C Le Deroff
- Grand accélérateur National d'Ions Lourds (GANIL), CEA/DRF-CNRS/IN2P3, Boulevard Henri Becquerel, 14076 Caen, France. Author to whom any correspondence should be addressed
| | | | | |
Collapse
|